The Creative Disruption Forum (CDF) Oxford, scheduled for Wednesday, 10 June 2026, is a premier high-impact gathering dedicated to exploring The Future of Neuro Therapeutics and CNS Health Innovations.
Hosted at the Magdalen Centre within the Oxford Science Park, this intensive, day-long forum (10:00 AM – 4:30 PM) is specifically designed to spark new ideas, challenge status-quo thinking, and build deep peer-to-peer connections across the UK life sciences ecosystem.
What the Forum Covers
The event bridges the gap between ground-breaking research and the commercial realities of getting life-changing treatments to patients. Key areas of focus include:
• The Funding Landscape: Answering the critical question on every innovator's mind: "Where is the funding coming from?" The session dives into navigating private venture capital, public investments, and collaborative funding initiatives.
• Translational Medicine: Overcoming commercialisation barriers to move neuro-focused discoveries seamlessly from the lab bench to clinical reality.
• Interactive Workshops: Moving away from standard, dry lecture formats, the afternoon shifts into collaborative peer-to-peer workshops to debate morning insights and share lessons learned.
Leading Minds in Attendance
The forum brings together an exceptional lineup of central figures driving UK Neuro Drug Discovery and Development. Guided by resident thought leader Prof. Tony Sedgwick and co-host Graham Combe, the event features leading minds from emerging biotech, biopharma, and academic research institutions, including:
Peter Hamley, Scripta Tx
Prof Fiona Ducotted, Alzehmeiers Research UK Discovery Unity, UCL
Prof Emma Mead,Alzehmeiers Research UK Discovery Unity, University of Oxford
Rob Johnson, Kesmalea Tx
Fraser Murray, Pheno Tx and Advent Life Sciences
Ron Jortner, Aspire Tx
Per Lundin , Evox Tx
Chris Tame, Trenary Tx
Tony Lockett, Nevrargenics
Laurence Barker, Dementia Fund - TBC
Jenny Laird, VP Neuroscience, Lilly
Madeline Wakeling, Harness Tx
Damian Crowther, Trimtech Tx
Emad Moeendarbary, UCL & BioRecode
Hiromasa Mori, EPOC Science
Jamie Bilsland, Acionna Tx - TBC
Ecosystem Synergy: This year’s Oxford event is uniquely positioned as part of a broader regional expansion, collaborating closely with the Cambridge Wide Open Week (CWOW) initiated by the o2h Group, creating a powerful innovation bridge between the UK's leading life science hubs.
Whether you are a biotech founder, an R&D director, a healthcare investor, or an aspiring industry leader looking to navigate the complex landscape of central nervous system (CNS) health, the Creative Disruption Forum offers an unfiltered, highly interactive space to help push the boundaries of neuro therapeutics.
